RealTeaNewsUntold WorldNews

Guinea-Bissau cancels US-funded hepatitis B newborn vaccine trial

The government refused to authorise a study that would have withheld a WHO-recommended birth dose from half of about 14,000 newborns. Police seized a vaccine batch from the Bandim project in October.

Published

RTN graphic: Guinea-Bissau vaccine trial halted
RTN graphic card. Not a photograph of Bandim facilities. RealTeaNews graphic.

Guinea-Bissau has cancelled a proposed US-funded hepatitis B vaccine trial on newborns after international criticism that the design was unethical, the BBC reported on 5 November. Researchers say the trial never enrolled babies.

What was planned

The Bandim Health Project study was designed for about 14,000 newborns, with half receiving a hepatitis B shot shortly after birth and half not, the BBC says. Critics focused on withholding a WHO-recommended birth-dose vaccine in a country where nearly one in five people has hepatitis B.

The Trump administration funded the proposal, with the CDC awarding the University of Southern Denmark $1.6m in December 2025, per the BBC. Private partners were also reported in earlier Guardian coverage.

Government refusal and police seizure

Health Minister Quinhin Nantote said the January prohibition on hepatitis B vaccine trials involving children remained in force and that he was “outraged” by media claims the study might proceed without him being informed, the BBC reports.

On 19 October, judicial police searched Bandim facilities in Bissau and seized a batch of hepatitis B vaccines. Police stressed the seizure did not itself mean the vaccines were defective. SDU dean Jakob Grauslund said no babies had been enrolled and no research vaccinations given.

Bandim researcher Frederik Schaltz-Buchholzer wrote that the trial would not move forward without governmental go-ahead, according to Al Jazeera and the Guardian.

WHO view

Walter Kazadi Mulombo, WHO representative in Guinea-Bissau, told the BBC a study that withholds a proven newborn intervention is unethical, citing more than 30 years of use in more than 115 countries.

What we do not know

  • Final disposition of the seized vaccine batch.
  • Whether any redesigned protocol will ever be proposed elsewhere.
  • Any US HHS comment; the BBC said it had asked for one.

Nobody was contacted.

Sources

  1. US-funded vaccine trial on babies cancelled in Guinea-Bissau after uproar, BBC News. Accessed 6 November 2026.
  2. Why Guinea-Bissau halted a controversial hepatitis vaccine trial for babies, Al Jazeera. Accessed 6 November 2026.
  3. Controversial US-backed vaccine trial in African newborns halted, the Guardian. Accessed 6 November 2026.

Sources link to external sites. Their content is the responsibility of their publishers.

More in Untold World